These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 34009296)
21. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors. Li Y; Li X; Fan G; Fukushi J; Matsumoto Y; Iwamoto Y; Zhu Y Cancer Lett; 2012 Jul; 320(1):14-22. PubMed ID: 22266186 [TBL] [Abstract][Full Text] [Related]
23. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor. Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530 [TBL] [Abstract][Full Text] [Related]
24. Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein. Paronetto MP; Bernardis I; Volpe E; Bechara E; Sebestyén E; Eyras E; Valcárcel J Cell Rep; 2014 May; 7(4):1211-26. PubMed ID: 24813895 [TBL] [Abstract][Full Text] [Related]
25. Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma. Wang S; Huo X; Yang Y; Mo Y; Kollipara RK; Kittler R Cancer Lett; 2023 Jan; 552():215984. PubMed ID: 36330954 [TBL] [Abstract][Full Text] [Related]
26. Mithramycin A Radiosensitizes EWS:Fli1 Lin MY; Damron TA; Oest ME; Horton JA Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1454-1471. PubMed ID: 33373655 [TBL] [Abstract][Full Text] [Related]
27. Participation of nuclear localization signal 2 in the 3'-ETS domain of FLI1 in nuclear translocation of various chimeric EWS-FLI1 oncoproteins in Ewing tumor. Honsei N; Ikuta T; Kawana K; Kaneko Y; Kawajiri K Int J Oncol; 2006 Sep; 29(3):689-93. PubMed ID: 16865286 [TBL] [Abstract][Full Text] [Related]
28. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. McKinsey EL; Parrish JK; Irwin AE; Niemeyer BF; Kern HB; Birks DK; Jedlicka P Oncogene; 2011 Dec; 30(49):4910-20. PubMed ID: 21643012 [TBL] [Abstract][Full Text] [Related]
29. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Mutz CN; Schwentner R; Aryee DNT; Bouchard EDJ; Mejia EM; Hatch GM; Kauer MO; Katschnig AM; Ban J; Garten A; Alonso J; Banerji V; Kovar H Oncotarget; 2017 Apr; 8(15):24679-24693. PubMed ID: 28160567 [TBL] [Abstract][Full Text] [Related]
30. EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma. Apfelbaum AA; Wu F; Hawkins AG; Magnuson B; Jiménez JA; Taylor SD; Wrenn ED; Waltner O; Pfaltzgraff ER; Song JY; Hall C; Wellik DM; Ljungman M; Furlan SN; Ryan RJH; Sarthy JF; Lawlor ER Clin Cancer Res; 2022 Oct; 28(20):4466-4478. PubMed ID: 35653119 [TBL] [Abstract][Full Text] [Related]
31. EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells. Croushore EE; Stipp CS; Gordon DJ Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201282 [TBL] [Abstract][Full Text] [Related]
32. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1. Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820 [TBL] [Abstract][Full Text] [Related]
33. EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma. Shi X; Zheng Y; Jiang L; Zhou B; Yang W; Li L; Ding L; Huang M; Gery S; Lin DC; Koeffler HP Nucleic Acids Res; 2020 Nov; 48(20):11434-11451. PubMed ID: 33080033 [TBL] [Abstract][Full Text] [Related]
34. Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone. Park H; Turkalo TK; Nelson K; Folmsbee SS; Robb C; Roper B; Azuma M Cell Cycle; 2014; 13(15):2391-9. PubMed ID: 25483190 [TBL] [Abstract][Full Text] [Related]
35. EWS-FLI1 positively regulates autophagy by increasing ATG4B expression in Ewing sarcoma cells. Lu Q; Zhang Y; Ma L; Li D; Li M; Li J; Liu P Int J Mol Med; 2017 Oct; 40(4):1217-1225. PubMed ID: 28902354 [TBL] [Abstract][Full Text] [Related]
36. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis. Stoll G; Surdez D; Tirode F; Laud K; Barillot E; Zinovyev A; Delattre O Nucleic Acids Res; 2013 Oct; 41(19):8853-71. PubMed ID: 23935076 [TBL] [Abstract][Full Text] [Related]
37. Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor. Osgood CL; Maloney N; Kidd CG; Kitchen-Goosen S; Segars L; Gebregiorgis M; Woldemichael GM; He M; Sankar S; Lessnick SL; Kang M; Smith M; Turner L; Madaj ZB; Winn ME; Núñez LE; González-Sabín J; Helman LJ; Morís F; Grohar PJ Clin Cancer Res; 2016 Aug; 22(16):4105-18. PubMed ID: 26979396 [TBL] [Abstract][Full Text] [Related]
38. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725 [TBL] [Abstract][Full Text] [Related]
39. The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma. Boone MA; Taslim C; Crow JC; Selich-Anderson J; Byrum AK; Showpnil IA; Sunkel BD; Wang M; Stanton BZ; Theisen ER; Lessnick SL Oncogene; 2021 Jul; 40(29):4759-4769. PubMed ID: 34145397 [TBL] [Abstract][Full Text] [Related]
40. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. Kovar H Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]